Latest News

The company Boehringer Ingelheim is continuing its support for the Gutenberg Health Study (GHS) with a sum of three million Euros by the end of 2017. Thereby, the GHS which started in 2007 is backed up until the end of that year. The aim is to build a biobank based on the data...

Göttingen pharmacologists led by DZHK - scientist Prof. Dr. Ali El - Armouche explore new therapy for heart failure: they activate the heart’s self-protection systems through targeted stimulation.

Currently, there is no therapy for myocardial weakness that can stop the...

Scientific know-how and skills of external partners are sought after in the German Centre for Cardiovascular Research (DZHK). Therefore it is now possible for scientists and institutions which are non-members of the DZHK to offer their specific methods or laboratory procedures...